glp-1 impact on alcohol consumption Physiological and perceptual effects of receptor agonists during in people with obesity: a pilot study A Lancet RCT just showed

It is definitely exciting to have more options for patients, even though we know there will inevitably be insurance coverage hurdles to jump through

Some people see improvement within weeks, while others need the full treatment course to achieve clear skin

Many of the patients who received vials of compounded semaglutide lacked experience with self-injections, according to the adverse event reports

Obes Rev (2019) 20:80515

A second randomized controlled trial randomized women with both diet-controlled and medically treated GDM to IOL at 38 to 38+6 weeks or expectant management until 41 weeks' gestation

For NYC patients approaching Medicare or already enrolled in Part D, this may become an important bridge between todays uneven obesity-drug coverage and broader future access